Dashboard
Manage Tickers

EMBC

Nasdaq embecta.com


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 612.91 nm (nm)
DIA $ 469.80 $ -3.83 (-0.81 %)
SPY $ 671.75 nm (nm)
TLT $ 89.73 nm (nm)
GLD $ 365.78 $ -0.44 (-0.12 %)
$ 13.46
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2025 06-30-2025 10-Q
2 05-09-2025 03-31-2025 10-Q
3 02-06-2025 12-31-2024 10-Q
4 12-11-2024 09-30-2024 10-K
5 08-09-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 02-09-2024 12-31-2023 10-Q
8 11-29-2023 09-30-2023 10-K
9 08-08-2023 06-30-2023 10-Q
10 05-12-2023 03-31-2023 10-Q
11 02-14-2023 12-31-2022 10-Q
12 12-22-2022 09-30-2022 10-K
13 08-15-2022 06-30-2022 10-Q
14 05-13-2022 03-31-2022 10-Q
15 03-16-2022 12-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

btig-reiterates-buy-on-embecta-maintains-25-price-target
BTIG Reiterates Buy on Embecta, Maintains ...
09/08/2025 09:58:32

BTIG analyst Marie Thibault reiterates Embecta (NASDAQ:EMBC) with a Buy and maintains $25 price target.

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
08/08/2025 12:08:44

embecta-raises-fy2025-adj-eps-guidance-from-270-290-to-290-295-vs-282-est-narrows-fy2025-sales-guidance-from-1073b-1090b-to-1078b-1085b-vs-1083b-est
Embecta Raises FY2025 Adj EPS Guidance fro...
08/08/2025 10:32:51

Fiscal Year 2025 Updated Financial Guidance:For fiscal year 2025, the Company now expects:Dollars in millions, except percentag...

embecta-q3-2025-adj-eps-112-beats-076-estimate-sales-295500m-beat-278228m-estimate
Embecta Q3 2025 Adj. EPS $1.12 Beats $0.76...
08/08/2025 10:30:57

Core News & Articles
Earnings Scheduled For August 8, 2025
08/08/2025 08:32:13

an-overview-of-embectas-earnings
An Overview of Embecta's Earnings
08/07/2025 15:03:10

mizuho-maintains-neutral-on-embecta-lowers-price-target-to-12
Mizuho Maintains Neutral on Embecta, Lower...
07/16/2025 12:25:23

Mizuho analyst Anthony Petrone maintains Embecta (NASDAQ:EMBC) with a Neutral and lowers the price target from $13 to $12.

mizuho-maintains-neutral-on-embecta-lowers-price-target-to-13
Mizuho Maintains Neutral on Embecta, Lower...
05/23/2025 17:40:21

Mizuho analyst Anthony Petrone maintains Embecta (NASDAQ:EMBC) with a Neutral and lowers the price target from $15 to $13.

embecta-reaffirms-2025-outlook-with-up-to-109b-revenue-unveils-long-term-plan-to-cut-500m-debt
Embecta Reaffirms 2025 Outlook With Up to ...
05/22/2025 10:35:30

Embecta Corp. ("embecta"; "The Company") (NASDAQ:EMBC), a global diabetes care company with a 100-year legacy i...

why-is-embecta-stock-falling-on-friday
Why Is Embecta Stock Falling On Friday?
05/09/2025 16:10:55

Embecta reaffirms earnings outlook, trims revenue forecast, and boosts cash flow as restructuring and cost controls offset tari...

embecta-affirms-fy2025-adj-eps-guidance-of-270-290-vs-280-est-lowers-fy2025-sales-guidance-of-107b-109b-vs-109b-est
Embecta Affirms FY2025 Adj EPS Guidance of...
05/09/2025 10:32:33

Embecta (NASDAQ:EMBC) affirms FY2025 Adj EPS guidance from $2.70-$2.90 to $2.70-$2.90 vs $2.80 analyst estimate. Lowers FY2025 ...

embecta-q2-adj-eps-070-beats-053-estimate-sales-25900m-beat-25394m-estimate
Embecta Q2 Adj. EPS $0.70 Beats $0.53 Esti...
05/09/2025 10:31:36

Embecta (NASDAQ:EMBC) reported quarterly earnings of $0.70 per share which beat the analyst consensus estimate of $0.53 by 32.0...

Core News & Articles
Earnings Scheduled For May 9, 2025
05/09/2025 08:32:15

a-peek-at-embectas-future-earnings
A Peek at Embecta's Future Earnings
05/08/2025 15:02:03

mizuho-initiates-coverage-on-embecta-with-neutral-rating-announces-price-target-of-15
Mizuho Initiates Coverage On Embecta with ...
04/10/2025 11:24:41

Mizuho analyst Anthony Petrone initiates coverage on Embecta (NASDAQ:EMBC) with a Neutral rating and announces Price Target ...

becton-dickinson-q1-earnings-revenue-and-eps-beat-lowers-outlook-outlines-intent-to-separate-biosciences-and-diagnostic-solutions-business
Becton Dickinson Q1 Earnings: Revenue And ...
02/06/2025 15:24:28

Becton Dickinson plans to spin off its Biosciences and Diagnostic Solutions unit, targeting a fiscal 2026 completion, while upd...

embecta-affirms-fy2025-adj-eps-guidance-from-270-290-to-270-290-vs-281-est-lowers-fy2025-sales-guidance-from-109b-111b-to-107b-109b-vs-110b-est
Embecta Affirms FY2025 Adj EPS Guidance fr...
02/06/2025 11:36:54

Embecta (NASDAQ:EMBC) affirms FY2025 Adj EPS guidance from $2.70-2.90 to $2.70-2.90 vs $2.81 analyst estimate. Lowers FY2025 sa...

embecta-q1-2025-adj-eps-065-beats-044-estimate-sales-261900m-beat-254617m-estimate
Embecta Q1 2025 Adj. EPS $0.65 Beats $0.44...
02/06/2025 11:35:17

Embecta (NASDAQ:EMBC) reported quarterly earnings of $0.65 per share which beat the analyst consensus estimate of $0.44 by 47.7...

earnings-scheduled-for-february-6-2025
Earnings Scheduled For February 6, 2025
02/06/2025 08:32:30

activist-starboard-value-pushes-becton-dickinson-to-divest-life-sciences-unit
Activist Starboard Value Pushes Becton Dic...
02/03/2025 18:06:05

Activist investor Starboard Value is urging Becton Dickinson to sell its life sciences division, citing potential value gains. ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION